Skip to main content

Indian Pharma Network

PROCYSBI (Cysteamine Bitartrate) Delayed-Release Capsules

  • Medicine Name: PROCYSBI
  • Active Ingredient (API): Cysteamine bitartrate
  • Dosage Form & Strength: Capsules: 25 mg / 75 mg delayed-release
  • Manufactured By: Horizon Therapeutics (now Amgen)

Medical Uses

PROCYSBI (cysteamine bitartrate) delayed-release capsules, from Horizon Therapeutics (now Amgen), are indicated for the treatment of nephropathic cystinosis in adults and children 1 year of age and older.

Cysteamine reacts with cystine trapped inside lysosomes of cystinosis patients, converting it into compounds that can exit the cell, thereby depleting the harmful cystine accumulation that damages the kidneys, eyes, and other organs. PROCYSBI’s delayed-release formulation allows twice-daily (rather than every-6-hour) dosing.

Warnings & Precautions

  • Gastrointestinal ulceration and bleeding have been reported.
  • Skin and bone lesions (including leukopenia and skin/bone abnormalities) have been reported with long-term cysteamine use.
  • Should not be taken with food; must be taken on an empty stomach as directed.
  • Central nervous system effects such as drowsiness or lethargy may occur.
  • Requires regular monitoring of white blood cell count and other lab parameters.

Documentation & Availability

What documents are required to import PROCYSBI to India?

PROCYSBI may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:

  • A valid prescription from a registered nephrologist/metabolic disease specialist
  • Diagnostic report confirming nephropathic cystinosis
  • Patient ID proof (issued by the Government of India)
How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription.

Is PROCYSBI available in India?

PROCYSBI is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).

Sourcing & Delivery

Indian Pharma Network (IPN) can source PROCYSBI from its authorized distribution network and facilitate supply to patients, doctors, and hospitals under applicable legal provisions.

For PROCYSBI cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

  • United States: Approved by the FDA — April 2013.

FAQ

What is PROCYSBI used for?

PROCYSBI treats nephropathic cystinosis, a rare genetic disorder causing cystine buildup that damages the kidneys and other organs.

Who manufactures PROCYSBI?

PROCYSBI is manufactured by Amgen (previously Horizon Therapeutics).

How is PROCYSBI taken?

As delayed-release capsules, typically every 12 hours on an empty stomach.

How much does PROCYSBI cost in India?

Cost depends on monthly quantity and sourcing logistics — share your prescription with IPN for a quote.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

Product Enquiry